Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
24.98
0.02 (0.08%)
At close: Aug 14, 2025, 3:59 PM
24.97
-0.04%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Janux Therapeutics Revenue

Janux Therapeutics reported an annual revenue of $10.59M, reflecting a 30.99% growth. For the quarter ending June 30, 2025, Janux Therapeutics generated $0 in revenue.
Revenue (ttm)
10.59M
Revenue Growth
30.99%
Price / Sales Ratio
271.8
Revenue / Employee
116.35K
Employees
91
Market Cap
1.5B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.